血管紧张素II对人肠系膜动脉血管平滑肌细胞大电导钙激活钾通道的激活效应  

Angiotensin II activates large-conductance Ca^(2+)-activated potassium channels in human mesenteric artery smooth muscle cells

作　　者：文静[1] 程俊[1] 李鹏云[1] 毛亮[1] 岳晓兰[1] 李畅[1] 杨艳[1] 

机构地区：[1]泸州医学院心肌电生理学研究室、泸州医学院心肌电生理学省部共建教育部重点实验室,泸州646000

出　　处：《生理学报》2013年第1期39-46,共8页Acta Physiologica Sinica

基　　金：supported by the National Natural Science Foundation of China(No.30670763)

摘　　要：本文旨在研究血管紧张素Ⅱ(angiotensinⅡ,AngⅡ)对人肠系膜动脉平滑肌细胞大电导钙激活钾通道(large conductance calcium-activated potassium channels,BKCa)的影响,探讨AngⅡ在分子水平扩张血管的作用机制。采用单通道膜片钳及全细胞穿孔膜片钳技术观察人肠系膜动脉平滑肌细胞BKCa对AngⅡ的反应性;采用RT-PCR技术确定人肠系膜动脉上AngⅡ受体基因的表达情况。在细胞贴附式膜片下(Vm=+40mV),直接加入AngⅡ(100nmol/L),人肠系膜动脉平滑肌细胞BKCa的活性无明显变化;经AngⅡ1型受体(angiotensinⅡtype 1 receptor,AT1R)特异性阻断剂缬沙坦(10μmol/L)预处理后,再分别加入25、100和250nmol/L的AngⅡ,BKCa的开放概率明显增加,呈现出浓度依赖性。缬沙坦预处理后,当加入100nmol/LAngⅡ时,BKCa的开放概率由0.010±0.003增至0.039±0.015,平均关闭时间由(2729.5±808.6)ms减至(487.7±182.5)ms(n=11,P<0.05),但平均开放时间和电流幅值在给药前后无明显变化。BKCa被AngⅡ(100nmol/L)激活后,再加入AngⅡ2型受体(angiotensinⅡtype 2 receptor,AT2R)特异性阻断剂PD123,319,BKCa的活性受到抑制,开放概率由0.016±0.003减至0.004±0.001(n=5,P<0.05),而通道平均开放时间、平均关闭时间和电流幅值在给药前后均无明显变化。另外,将人肠系膜动脉平滑肌细胞经缬沙坦和PD123,319共同处理后再加入AngⅡ(100nmol/L),BKCa的活性无明显变化。在全细胞穿孔膜片钳下,平滑肌细胞经缬沙坦(10μmol/L)预处理后,在测试的电压范围内,AngⅡ(100nmol/L)对膜电位从60mV到+30mV时BKCa电流密度均无明显影响,而在+40、+50和+60mV时,BKCa电流密度分别从(9.03±2.23)pA/pF、(12.88±2.55)pA/pF和(17.26±2.84)pA/pF增加到(12.47±2.22)pA/pF、(18.71±2.51)pA/pF和(27.21±3.12)pA/pF(n=6,P<0.05)。经RT-PCR证实人肠系膜动脉上有AT1R和AT2R这两种AngⅡ受体基因的表达。上述结果提示,AngⅡ对经缬沙坦预处理的人肠系膜动脉平滑肌细胞BKThe aim of present study was to explore the vasodilatation mechanism of angiotensin Ⅱ （AngⅡ） at the molecular level by investigating the effect of AngⅡ on large-conductance Ca2＋-activated potassium channels （BKca） in human mesenteric artery smooth muscle cells. The effect of AngII on BKca was observed by using patch clamp single channel recording technique and amphotericin- perforated whole-cell recording technique. AngII type 1 receptor （AT1R） and AngII type 2 receptor （AT2R） mRNA expression in human mesenteric artery was detected by RT-PCR. In cell-attached patch （Vm = ＋40 mV）, AngⅡ （100 nmol/L） had no significant effect on BKca. After pretreatment with Valsartan （a specific inhibitor of AT1R, 10 μmol/L）, 25, 100 and 250 nmol/L AngII stimulated BKca activity significantly in a dose response manner. After pretreatment of Valsartan, AngⅡ（100 nmol/L） enhanced BKc, open proba-bility （NPo） from 0.010 ± 0.003 to 0.039 ±0.015, decreased the mean close time （Tc） of BKca markedly from （2 729.5 ± 808.6） ms to （487.7 ± 182.5） ms （n = 11, P 〈 0.05）, but AnglI had no significant influences on the amplitude （Amp） and the mean open time （To） of BKca. Further PD123,319 （a specific inhibitor of AT2R） treatment prevented the stimulatory effect of AngⅡ： PD123,319 decreased the NPo of BKca from 0.016 ± 0.003 to 0.004 ± 0.001 （n = 5, P 〈 0.05）, but had no significant influences on Amp, To and Tc of BKca. In addition, after pretreatment with Valsartan and PD 123,319, AngⅡ （100 nmol/L） had no significant effect on BKca. In the amphoteri- cin-perforated whole-cell patch-clamp configuration, after pretreatment with Valsartan, the current density of BKca at the voltage of -60 - ＋30 mV had no significant changes before and after adding 100 nmol/L AnglI, but the current density of BKca at the voltage of ＋40 mV, ＋50 mV and ＋60 mV increased significantly after adding 100 nmol/L AnglI, from （9.03 ± 2.23） pA/pF, （12.88±2.55�

关 键 词：血管紧张素Ⅱ 血管紧张素Ⅱ 2型受体 大电导钙激活钾通道 人肠系膜动脉 

分 类 号：R331[医药卫生—人体生理学]